Oxidative stress in optic neuropathies
Research output: Contribution to journal › Review › Research › peer-review
Standard
Oxidative stress in optic neuropathies. / Sanz-Morello, Berta; Ahmadi, Hamid; Vohra, Rupali; Saruhanian, Sarkis; Freude, Kristine Karla; Hamann, Steffen; Kolko, Miriam.
In: Antioxidants, Vol. 10, No. 10, 1538, 2021.Research output: Contribution to journal › Review › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Oxidative stress in optic neuropathies
AU - Sanz-Morello, Berta
AU - Ahmadi, Hamid
AU - Vohra, Rupali
AU - Saruhanian, Sarkis
AU - Freude, Kristine Karla
AU - Hamann, Steffen
AU - Kolko, Miriam
N1 - Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021
Y1 - 2021
N2 - Increasing evidence indicates that changes in the redox system may contribute to the pathogenesis of multiple optic neuropathies. Optic neuropathies are characterized by the neurodegeneration of the inner-most retinal neurons, the retinal ganglion cells (RGCs), and their axons, which form the optic nerve. Often, optic neuropathies are asymptomatic until advanced stages, when visual impairment or blindness is unavoidable despite existing treatments. In this review, we describe systemic and, whenever possible, ocular redox dysregulations observed in patients with glaucoma, ischemic optic neuropathy, optic neuritis, hereditary optic neuropathies (i.e., Leber’s hereditary optic neuropathy and autosomal dominant optic atrophy), nutritional and toxic optic neuropathies, and optic disc drusen. We discuss aspects related to anti/oxidative stress biomarkers that need further investigation and features related to study design that should be optimized to generate more valuable and comparable results. Understanding the role of oxidative stress in optic neuropathies can serve to develop therapeutic strategies directed at the redox system to arrest the neurodegenerative processes in the retina and RGCs and ultimately prevent vision loss.
AB - Increasing evidence indicates that changes in the redox system may contribute to the pathogenesis of multiple optic neuropathies. Optic neuropathies are characterized by the neurodegeneration of the inner-most retinal neurons, the retinal ganglion cells (RGCs), and their axons, which form the optic nerve. Often, optic neuropathies are asymptomatic until advanced stages, when visual impairment or blindness is unavoidable despite existing treatments. In this review, we describe systemic and, whenever possible, ocular redox dysregulations observed in patients with glaucoma, ischemic optic neuropathy, optic neuritis, hereditary optic neuropathies (i.e., Leber’s hereditary optic neuropathy and autosomal dominant optic atrophy), nutritional and toxic optic neuropathies, and optic disc drusen. We discuss aspects related to anti/oxidative stress biomarkers that need further investigation and features related to study design that should be optimized to generate more valuable and comparable results. Understanding the role of oxidative stress in optic neuropathies can serve to develop therapeutic strategies directed at the redox system to arrest the neurodegenerative processes in the retina and RGCs and ultimately prevent vision loss.
KW - Glaucoma
KW - Mitochondria
KW - Optic disc drusen
KW - Optic neuropathy
KW - Oxidative stress
KW - Redox dysregulations
KW - Retinal ganglion cell
U2 - 10.3390/antiox10101538
DO - 10.3390/antiox10101538
M3 - Review
C2 - 34679672
AN - SCOPUS:85115884920
VL - 10
JO - Antioxidants
JF - Antioxidants
SN - 2076-3921
IS - 10
M1 - 1538
ER -
ID: 281156683